The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, affecting approximately one-quarter of the global population, and has become a world public health issue. NAFLD is a clinicopathological syndrome characterized by hepatic steatosis, excluding ethanol and other definite liver damage factors. Recent studies have shown that the development of NAFLD is associated with lipid accumulation, oxidative stress, endoplasmic reticulum stress, and lipotoxicity. A range of natural products have been reported as regulators of NAFLD in vivo and in vitro. This paper reviews the pathogenesis of NAFLD and some natural products that have been shown to have therapeutic effects on NAFLD. Our work shows that natural products can be a potential therapeutic option for NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, H. Y., Lee, G., Lee, M. R., Kim, H.-K., Kim, N.-Y., Kim, S., Lee, Y.-C., Kim, H., & Chae, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081349 · Cited by 57
RetractedYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Membrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · cited 1×
“With the global increase in metabolic syndrome, obesity and diabetes, the prevalence of NAFLD has risen dramatically, affecting about a quarter of the world’s population [6].”
BackgroundEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 2,988
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 2×
“when the transport of fatty acids to the mitochondria is reduced [58,59].”
BackgroundDefective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Chen, Z., Tian, R., She, Z., Cai, J., & Li, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.025 · Cited by 1,279
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,132
New trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S.-U., & Wong, V. W.-S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,083
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Targeting the unfolded protein response in disease
Hetz, C., Chevet, E., & Harding, H. P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3976 · Cited by 910
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847 · cited 2×
“Lipotoxicity is the toxic effect of sustained high concentrations of lipids and metabolites deposited excessively in nonadipose tissue, causing damage to that tissue [78].”
BackgroundMitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732 · cited 1×
“It has been reported that ER stress promotes the activation of the adipogenic transcription factor SREBP-1c, thereby promoting adipogenesis [71,72].”
BackgroundWong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c
Ferré, P., & Foufelle, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01275.x · Cited by 704
Metabolic-associated fatty liver disease and lipoprotein metabolism
Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 646
Ricchi, M., Odoardi, M. R., Carulli, L., Anzivino, C., Ballestri, S., Pinetti, A., Fantoni, L. I., Marra, F., Bertolotti, M., Banni, S., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05733.x · Cited by 645
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627 · cited 1×
“Insulin has an anti-lipolytic effect, mediates TG storage in adipose tissue, and promotes esterification and storage of fatty acids [22].”
BackgroundDe novo lipogenesis in health and disease
Ameer, F., Scandiuzzi, L., Hasnain, S., Kalbacher, H., & Zaidi, N. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.003 · Cited by 611
Molecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 610
Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 597
Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
Milić, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9330 · Cited by 583
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores.
Zechner, R., Kienesberger, P. C., Haemmerle, G., Zimmermann, R., & Lass, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800031-jlr200 · Cited by 576
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 554
Pathogenesis of Nonalcoholic Steatohepatitis
Machado, M. V., & Diehl, A. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.066 · Cited by 539
Leoni, S., Tovoli, F., Napoli, L., Serio, I., Ferri, S., & Bolondi, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i30.3361 · Cited by 539
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
Dietrich, P., & Hellerbrand, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.008 · Cited by 457
Li, J., Wang, T., Liu, P., Yang, F., Wang, X., Zheng, W., & Sun, W. (2021) · Food & Function · doi:10.1039/d0fo02736g · Cited by 450
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
Song, Z., Xiaoli, A. M., & Yang, F. (2018) · Nutrients · doi:10.3390/nu10101383 · Cited by 435
Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R. B., Girard, J., & Postic, C. (2006) · Diabetes · doi:10.2337/db06-0200 · Cited by 433
Nonalcoholic fatty liver disease and the metabolic syndrome
Marchesini, G., Marzocchi, R., Agostini, F., & Bugianesi, E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174153.53683.f2 · Cited by 418
Mitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 391
PPARα: Energy Combustion, Hypolipidemia, Inflammation and Cancer
Pyper, S. R., Viswakarma, N., Yu, S., & Reddy, J. K. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08002 · Cited by 379
Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M., & Azarbayjani, M. A. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2019.1571114 · Cited by 379
Lê, K.-A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., Boesch, C., & Tappy, L. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27336 · Cited by 369
Beuers, U., Hohenester, S., de Buy Wenniger, L. J. M., Kremer, A. E., Jansen, P. L. M., & Elferink, R. P. J. O. (2010) · Hepatology · doi:10.1002/hep.23810 · Cited by 351 · cited 1×
“It has been demonstrated that bile acids disrupt cell membranes by dissolving phospholipids, cholesterol and fatty acids in lipid bilayers [82].”
BackgroundMusso, G., Cassader, M., Paschetta, E., & Gambino, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.031 · Cited by 332
Dietary fructose in nonalcoholic fatty liver disease
Vos, M. B., & Lavine, J. E. (2013) · Hepatology · doi:10.1002/hep.26299 · Cited by 314
Role of ceramides in nonalcoholic fatty liver disease
Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N., & Kirwan, J. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.04.005 · Cited by 303
Crosstalk between ER stress, NLRP3 inflammasome, and inflammation
Li, W., Cao, T., Luo, C., Cai, J., Zhou, X., Xiao, X., & Liu, S. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10614-y · Cited by 302
Nasiri-Ansari, N., Nikolopoulou, C., Papoutsi, K., Kyrou, I., Mantzoros, C. S., Kyriakopoulos, G., Chatzigeorgiou, A., Kalotychou, V., Randeva, M. S., Chatha, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020818 · Cited by 297
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Garcia, D., Hellberg, K., Chaix, A., Wallace, M., Herzig, S., Badur, M. G., Lin, T., Shokhirev, M. N., Pinto, A. F. M., Ross, D. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.036 · Cited by 293
V. Mitochondrial dysfunction in steatohepatitis
Pessayre, D., Mansouri, A., & Fromenty, B. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00426.2001 · Cited by 291
The ins and outs of mitochondrial dysfunction in NASH
Fromenty, B., Robin, M., Igoudjil, A., Mansouri, A., & Pessayre, D. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70098-8 · Cited by 266
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Svegliati-Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.029 · Cited by 249
Andrade, J. M. O., Paraíso, A. F., de Oliveira, M. V. M., Martins, A. M. E., Neto, J. F., Guimarães, A. L. S., de Paula, A. M., Qureshi, M., & Santos, S. H. S. (2014) · Nutrition · doi:10.1016/j.nut.2013.11.016 · Cited by 237
Fructose as a key player in the development of fatty liver disease
Basaranoglu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1166 · Cited by 235
Feng, X., Yu, W., Li, X., Zhou, F., Zhang, W., Shen, Q., Li, J., Zhang, C., & Shen, P. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.014 · Cited by 229
Lawitz, E. J., Coste, A., Poordad, F., Alkhouri, N., Loo, N., McColgan, B. J., Tarrant, J. M., Nguyen, T., Han, L., Chung, C., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.042 · Cited by 217
Non-alcoholic fatty liver disease: What the clinician needs to know
Machado, M. V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12956 · Cited by 204
Byrne, C. D., & Targher, G. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303034 · Cited by 179
From fatty liver to fibrosis: A tale of “second hit”
Basaranoglu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1158 · Cited by 176
Liu, Y., Xu, W., Zhai, T., You, J., & Chen, Y. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.006 · Cited by 175
Chyau, C.-C., Wang, H.-F., Zhang, W.-J., Chen, C.-C., Huang, S.-H., Chang, C.-C., & Peng, R. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21010360 · Cited by 173
Luukkonen, P. K., Qadri, S., Ahlholm, N., Porthan, K., Männistö, V., Sammalkorpi, H., Penttilä, A. K., Hakkarainen, A., Lehtimäki, T. E., Gaggini, M., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.013 · Cited by 170
Induction of Hepatitis by JNK-Mediated Expression of TNF-α
Das, M., Sabio, G., Jiang, F., Rincón, M., Flavell, R. A., & Davis, R. J. (2009) · Cell · doi:10.1016/j.cell.2008.11.017 · Cited by 166
Role of ChREBP in hepatic steatosis and insulin resistance
Denechaud, P.-D., Dentin, R., Girard, J., & Postic, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.07.084 · Cited by 163
Liou, C.-J., Lee, Y.-K., Ting, N.-C., Chen, Y.-L., Shen, S.-C., Wu, S.-J., & Huang, W.-C. (2019) · Cells · doi:10.3390/cells8050447 · Cited by 158
Shen, G. X. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-018 · Cited by 155
Li, Q., Tan, J., He, Y., Bai, F., Li, S., Hou, Y.-W., Ji, L., Gao, Y., Zhang, X., Zhou, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68873 · Cited by 139
Shen, B., Feng, H., Cheng, J., Li, Z., Jin, M., Zhao, L., Wang, Q., Qin, H., & Liu, G. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15139 · Cited by 136
Ziamajidi, N., Khaghani, S., Hassanzadeh, G., Vardasbi, S., Ahmadian, S., Nowrouzi, A., Ghaffari, S. M., & Abdirad, A. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.018 · Cited by 135
Qu, L., Yu, B., Li, Z., Jiang, W., Jiang, J., & Kong, W. (2015) · Phytotherapy Research · doi:10.1002/ptr.5541 · Cited by 133
Does fructose consumption contribute to non-alcoholic fatty liver disease?
Tappy, L., & Lê, K. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.06.005 · Cited by 127
Li, L., Fu, J., Liu, D., Sun, J. Y., Hou, Y., Chen, C., Shao, J., Wang, L., Wang, X., Zhao, R., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101412 · Cited by 125
Ectopic fat, insulin resistance and non-alcoholic fatty liver disease
Byrne, C. D. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001249 · Cited by 123
Mitochondrial involvement in non-alcoholic steatohepatitis
Serviddio, G., Sastre, J., Bellanti, F., Viña, J., Vendemiale, G., & Altomare, E. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.014 · Cited by 121
Zhang, C., Chen, X., Zhu, R.-M., Zhang, Y., Yu, T., Wang, H., Zhao, H. J., Zhao, M., Ji, Y., Chen, Y., et al. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.06.002 · Cited by 118
Huang, J., Jia, Y., Fu, T., Viswakarma, N., Bai, L., Rao, M. S., Zhu, Y., Borensztajn, J., & Reddy, J. K. (2011) · The FASEB Journal · doi:10.1096/fj.11-194019 · Cited by 116
Molecular signal networks and regulating mechanisms of the unfolded protein response
Gong, J., Wang, X., Wang, T., Chen, J., Xie, X., Hu, H. Z., Yu, F., Liu, H., Jiang, X., & Fan, H. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600043 · Cited by 114
Nonalcoholic steatohepatitis (NASH) – current treatment recommendations and future developments
Roeb, E., & Geier, A. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0784-8827 · Cited by 110
Endoplasmic Reticulum Stress and the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Gentile, C. L., Frye, M. A., & Pagliassotti, M. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3790 · Cited by 106
Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease
Mun, J., Kim, S., Yoon, H., You, Y., Kim, O., Choi, K., Lee, Y., Lee, J., Park, J., & Jun, W. (2019) · Nutrients · doi:10.3390/nu11102536 · Cited by 106
Zhou, Y. J., Ding, Y., Zhang, J.-L., Zhang, P., Wang, J.-Q., & Li, Z.-H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.035 · Cited by 104
Self-citationKim, J., Sim, H. A., Jung, D. Y., Lim, E. Y., Kim, Y. T., Kim, B. J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194801 · Cited by 104
Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver
Takamura, T., Misu, H., Ota, T., & Kaneko, S. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0228 · Cited by 102
Gao, Q., Jia, Y., Yang, G., Zhang, X., Boddu, P. C., Petersen, B. E., Narsingam, S., Zhu, Y.-J., Thimmapaya, B., Kanwar, Y. S., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.018 · Cited by 95
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems
Ross, T. T., Crowley, C., Kelly, K. L., Rinaldi, A., Beebe, D. A., Lech, M. P., Martinez, R. V., Carvajal-Gonzalez, S., Boucher, M., Hirenallur-Shanthappa, D., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.06.001 · Cited by 94
Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice
Fuchs, C. D., Claudel, T., Kumari, P., Haemmerle, G., Pollheimer, M. J., Stojaković, T., Scharnagl, H., Halilbasic, E., Gumhold, J., Silbert, D., et al. (2012) · Hepatology · doi:10.1002/hep.25601 · Cited by 89
Hendrikx, T., Walenbergh, S. M. A., Hofker, M. H., & Shiri‐Sverdlov, R. (2014) · Obesity Reviews · doi:10.1111/obr.12159 · Cited by 83
Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis
Flamment, M., Kammoun, H. L., Hainault, I., Ferré, P., & Foufelle, F. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283395e5c · Cited by 77
Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data
Yki‐Järvinen, H. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833f4b34 · Cited by 76
Lee, M. R., Yang, H. J., Park, K., & Yeul, J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.07.008 · Cited by 75
Li, S., Qian, Q., Ying, N., Lai, J., Feng, L., Zheng, S., Jiang, F., Song, Q., Chai, H., & Dou, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.560905 · Cited by 75
Misra, P., & Reddy, J. K. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.011 · Cited by 71
Salomone, F., Volti, G. L., Vitaglione, P., Morisco, F., Fogliano, V., Zappalà, A., Palmigiano, A., Garozzo, D., Caporaso, N., D’Argenio, G., et al. (2013) · Translational research · doi:10.1016/j.trsl.2013.12.001 · Cited by 70
Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway
Zhang, X., Ji, R., Sun, H., Peng, J., Ma, X., Wang, C., Fu, Y., Bao, L., & Jin, Y. (2018) · Free Radical Research · doi:10.1080/10715762.2017.1422602 · Cited by 66
Yu, L., Gong, L., Wang, C., Hu, N., Tang, Y.-Q., Li, Z., Dai, X., & Li, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s243893 · Cited by 57
Brady, L. J., Silverstein, L. J., Hoppel, C. L., & Brady, P. S. (1985) · Biochemical Journal · doi:10.1042/bj2320445 · Cited by 53
Citrus Peel Extract Ameliorates High-Fat Diet-Induced NAFLD via Activation of AMPK Signaling
Lee, G., Peng, C. Y., Park, S., Hoang, T., Lee, H., Kim, J., Kang, S., Lee, C.-H., Lee, J.-S., & Chae, H. (2020) · Nutrients · doi:10.3390/nu12030673 · Cited by 52
Zhu, L., Wang, A., Luo, P., Wang, X., Jiang, D.-S., Deng, W., Zhang, X., Wang, T., Liu, Y., Gao, L., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.011 · Cited by 51
Lee, J., Baek, S. Y., Jang, E. J., Ku, S., Kim, K. M., Ki, S. H., Kim, C.-E., Park, K., Kim, S. C., & Kim, Y. W. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.04.023 · Cited by 50
Hypolipidemic effects of flavonoids extracted from Lomatogonium rotatum
Bao, L., HU, L., Zhang, Y., & Wang, Y. I. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3038 · Cited by 44
Kim, B., Woo, M. J., Park, C. S., Lee, S., Kim, J., Kim, B., An, S., & Kim, S. (2016) · Phytotherapy Research · doi:10.1002/ptr.5741 · Cited by 44
Lee, G., Lee, H., Park, S., Shin, T.-S., & Chae, H. (2019) · Nutrients · doi:10.3390/nu11020426 · Cited by 43
Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice
Wu, S., Huang, W., Yu, M., Chen, Y.-L., Shen, S., Yeh, K., & Liou, C. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108602 · Cited by 42
Dong, Q., Majumdar, G., O’Meally, R. N., Cole, R. N., Elam, M. B., & Raghow, R. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03625-5 · Cited by 40
Shao, G., Liu, Y., Lu, L., Zhang, G., Zhou, W., Wu, T., Wang, L., Xu, H., & Ji, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944088 · Cited by 39
Study of some factors controlling fatty acid oxidation in liver mitochondria of obese Zucker rats
Clouet, P., Henninger, C., & Bezard, J. A. (1986) · Biochemical Journal · doi:10.1042/bj2390103 · Cited by 31
Liu, L., Yang, M. H., Lin, X., Li, Y., Liu, C., Yang, Y., Yamahara, J., Wang, J., & Li, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.10.020 · Cited by 28
Self-citationZhai, T., Xu, W., Liu, Y., Qian, K., Xiong, Y., & Chen, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2313641 · Cited by 26
Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis
Zheng, Y., Huang, C., Zhao, L., Chen, Y., & Liu, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112166 · Cited by 25
Wang, J., Hu, R., Yin, C., & Xiao, Y. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12510 · Cited by 22
Self-citationCho, J.-H., Lee, J.-S., Kim, H.-G., Lee, H. W., Fang, Z., Kwon, H. H., Kim, D. W., Lee, C., & Jeong, J.-W. (2021) · Antioxidants · doi:10.3390/antiox10070998 · Cited by 21
Wang, J., Hwang, S., Lim, D., & Son, C. (2021) · Cells · doi:10.3390/cells11010023 · Cited by 20
Self-citationSon, Y., Jung, D. S., Shin, J. M., Kim, M., Yoo, G., & Nho, C. W. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03212-6 · Cited by 15
Lee, M. R., Lee, H.-Y., Lee, G., et al. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500414 · Cited by 12
Tong, Y., Zhu, W., Wen, T., Mukhamejanova, Z., Xu, F., Xiang, Q., & Pang, J. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.2c00259 · Cited by 12
Shatoor, A. S., Humayed, S. A., & Almohiy, H. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13945 · Cited by 11
Jeon, B. T., Heo, R. W., Shin, H. J., Yi, C., Lee, Y. H., Joung, H.-N., Jung, J. H., Jung, J., Kim, S. K., Hahm, J. R., et al. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.882753 · Cited by 9
Cited by
Current status and future trends of the global burden of MASLD
Miao, L., Targher, G., Byrne, C. D., Cao, Y.-Y., & Zheng, M.-H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.007 · Cited by 781
Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331460 · Cited by 242
Shrestha, S., Jeon, J.-H., & Hong, C.-W. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0058 · Cited by 30
Varmazyar, I., Monazzami, A. A., Moradi, M., & McAinch, A. J. (2024) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-024-00972-9 · Cited by 7
PKM2 Drives Lactate-mediated Fibrosis in Liver Transplantation
Liu, J.-Y., Liao, W., Chen, Z.-Y., Liu, T., Wang, R., Gong, J.-P., Xu, X.-S., & Wu, H. (2025) · Transplantation · doi:10.1097/tp.0000000000005461 · Cited by 6
Metadata
- Authors
- Guo, X., Yin, X., Liu, Z., & Wang, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-07
- Volume
- 23
- Issue
- 24
- Pages
- 15489
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4311730330
- Cited by
- 412
- References
- 120
- FWCI
- 48.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.